Eric Lefkofsky is an incredibly successful businessman. According to Forbes Lefkofsky is worth $3.2 billion(USD) as of August, 2020. This success is all self-made through hard work and good business decisions. A more recent endeavor for Lefkofsky has been the founder and CEO of Tempus. A company that offers physicians, researchers, and patients access to clinical and molecular data. The connectivity it provides is in hopes of better patient outcomes and diagnoses. Eric Lefkofsky founded the company in 2015, and it is quickly growing. The company has a wide array of leaders as well as scientific advisors to ensure the company’s progress.
The company offers five areas of application for hospitals and physicians. For oncology, it offers molecular sequencing services and anatomic pathology testing. With their program in genomic sequencing, they can identify DNA and RNA abnormalities quickly and effectively. They are helping advance neurology and psychiatric care. Through exome germline sequencing they can suggest gene-drug interaction information. This can all be done with a simple saliva sample. Tempus is also able to connect institutional researchers and allow researchers to share findings. It also provides state of the art tools for biomarker research, development, and commercialization. Scientists and physicians are also hard at work identifying and understanding infectious diseases. The scientists are hard at work finding ways to identify COVID-19 patients who are asymptomatic. Eric Lefkifsky is leading the way towards a healthier tomorrow. Read More.